Ubrogepant

UBRELVY

Calcitonin Gene-related Peptide Receptor Antagonist

NADAC/unit $109.0773

No Shortage Tier 1: 31.6% PA Req: 150.8%

vs. brand UBRELVY: Generic saves up to -991% per unit

Covered Lives

Generic Manufacturers

ABBVIE INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Ubrogepant drfinder.aiFind doctors who prescribe Ubrogepant rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Ubrogepant

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.